SEC Company Response from Imunon, Inc. (IMNN) (CIK 0000749647) (IMNN) — Oct 10, 2018
Imunon, Inc. (IMNN) (CIK 0000749647)
Date: Oct. 10, 2018 · CIK: 0000749647 · Accession: 0001493152-18-014348
AI Filing Summary & Sentiment
File numbers found in text: 333-227236
Show Raw Text
CORRESP
1
filename1.htm
Celsion
Corporation
997
Lenox Dr., Suite 100
Lawrenceville,
New Jersey 08648
October
10, 2018
VIA
EDGAR
Division
of Corporation Finance
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Ada Farmento
Re: Celsion
Corporation
Registration
Statement on Form S-3
Filed
September 28, 2018
File No. 333-227236
Dear
Ms. Farmento:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, Celsion Corporation, a Delaware corporation (the “Registrant”),
hereby requests that the effectiveness of the registration statement on Form S-3 (File No. 333-227236), as amended by Pre-Effective
Amendment No. 1, as filed with the Securities and Exchange Commission (the “Commission”) on September 28, 2018,
be accelerated so that the registration statement becomes effective at 4:30 p.m. Eastern Time, on October 12, 2018, or as soon
thereafter as practicable.
If
you have any questions or require any additional information with respect to any of the matters discussed in this letter, please
contact Sam Zucker of Sidley Austin LLP, counsel to the Registrant, at (650) 565-7111.
Very truly yours,
Celsion Corporation
By:
/s/
Jeffrey W. Church
Jeffrey
W. Church
Senior
Vice President and Chief Financial Officer
cc:
Michael
H. Tardugno, President and Chief Executive Officer, Celsion Corporation Sam Zucker, Sidley Austin LLP